Q2 FY2027 · ended Aug 31, 2026 · Revenue $3.20M, -1.1% YoY · Filed Oct 8, 2026
Medinotec Inc. (MDNC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2027, the quarter ended Aug 31, 2026, it reported revenue of $3.2 million and net income of $40,866. Free cash flow was $60,891. As of Aug 31, 2026 it held $2.6 million in cash and investments and $91,165 in total debt.
Revenue
$3.20M
-1.1% vs year-ago quarter
Net income
$40,866
-88.2% vs year-ago quarter
Operating cash flow
$107,526
-91.2% vs year-ago quarter
Free cash flow
$60,891
+128.1% vs prior quarter
EPS
$0.00
-100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
11.76M
+0.0% vs year-ago quarter
Net cash
$2.49M
Q2 FY2027
Operating margin
6.6%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDNC (OTC)
- Fiscal year ends
- February 28
- Incorporated in
- NV
- Headquarters
- Johannesburg
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1931055
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2027 Aug 31, 2026 |
Q1 FY2027 May 31, 2026 |
Q4 FY2026 Feb 28, 2026 |
Q3 FY2026 Nov 30, 2025 |
Q2 FY2026 Aug 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.2M | $2.7M | $1.8M | $2.5M | $3.2M |
| Operating income | $202,723 | $180,872 | -$264,222 | $552,712 | $528,565 |
| Net income | $40,866 | $222,014 | -$69,259 | $403,411 | $346,566 |
| Diluted EPS | $0.00 | — | — | — | $0.03 |
| Operating cash flow | $107,526 | -$176,125 | -$120,641 | $563,139 | $1.2M |
| Free cash flow | $60,891 | -$216,475 | -$209,637 | — | — |
| Total assets | $7.0M | $7.0M | $6.8M | $6.9M | $6.4M |
| Total liabilities | $1.0M | $1.1M | $1.1M | $1.4M | $1.5M |
| Stockholders' equity | $5.9M | $5.9M | $5.7M | $5.5M | $4.8M |
| Cash and investments | $2.6M | $2.5M | $2.8M | $2.9M | $2.2M |
| Total debt | $91,165 | $8,829 | $14,905 | $21,868 | $28,716 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 8, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Jul 9, 2026 | May 31, 2026 |
| 10-K | Annual report | May 28, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jan 20, 2026 | Jan 20, 2026 |
| 10-Q | Quarterly report | Jan 9, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 8, 2025 | Aug 31, 2025 |
All 54 Medinotec Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.